Erratum: Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial-Reference-Cited by-同舟云学术

Erratum: Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial

Published:2012-09-07 Issue:10 Volume:12 Page:740-740
ISSN:1474-1733
Container-title:Nature Reviews Immunology
language:en
Short-container-title:Nat Rev Immunol

Author:

Horvath Christopher,Andrews Laura,Baumann Andreas,Black Lauren,Blanset Diann,Cavagnaro Joy,Hastings Kenneth L.,Hutto David L.,MacLachlan Timothy K.,Milton Mark,Reynolds Theresa,Roberts Stan,Rogge Mark,Sims Jennifer,Treacy George,Warner Garvin,Green James D.

Publisher

Springer Science and Business Media LLC

Subject

Energy Engineering and Power Technology,Fuel Technology

Link

http://www.nature.com/articles/nri3302.pdf

Reference1 articles.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-human primates in the PKPD evaluation of biologics: Needs and options to reduce, refine, and replace. A BioSafe White Paper;mAbs;2022-11-23

2. Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release;Journal for ImmunoTherapy of Cancer;2021-11

3. First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach;Journal for ImmunoTherapy of Cancer;2020-04

4. Regulatory T cells in acute and chronic kidney diseases;American Journal of Physiology-Renal Physiology;2018-05-01

5. Special Commentary: Early Clinical Development of Cell Replacement Therapy: Considerations for the National Eye Institute Audacious Goals Initiative;Ophthalmology;2017-07